LeBlanc und Michel treffen sich mit der Pharmabranche, während die USA ihre Arzneimittelpreise senken
LeBlanc, Michel meet with pharma sector as U.S. buckles down on cutting drug prices
LeBlanc und Michel treffen sich mit der Pharmabranche, während die USA ihre Arzneimittelpreise senken
LeBlanc, Michel meet with pharma sector as U.S. buckles down on cutting drug prices
3 Kommentare
Spelling it out: they are preparing to buckle under Pharma pressure and raise Canadian drug prices.
U.S. consumers have been subsidizing lower drug prices in other countries.
Here comes the downvotes. Elbows up = votes down.
Why doesn’t the article mention our generic drug system? This system keeps drug prices down for Canadians and makes us less reliant on US pharma companies. More than 75% of prescriptions are filled this way. The article does mention focusing on domestic production but there’s a huge focus on the opinions of US pharma companies, which shouldn’t be our concern in my eyes.
Maybe someone smarter than can prove me wrong here but isn’t our best bet for keeping our drug prices down in the future to focus on continued domestic production and increasing innovation research? Not buying into this „cost of innovation“ pricing that the US wants us to pay.